Method of screening therapeutic agents for nerve...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C436S501000, C530S350000

Reexamination Certificate

active

10517956

ABSTRACT:
By using a G protein-coupled receptor protein containing an amino acid sequence, which is the same or the substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:10, SEQ ID NO:12 or SEQ ID NO:14, or its salt together with humanin, a compound or its salt capable of changing the binding properties of the above receptor protein or its salt to humanin can be efficiently screened.

REFERENCES:
patent: WO-01/21787C (2001-03-01), None
Y. Le et al., “The Journal of Neuroscience”, vol. 21, RC123, pp. 1-5, (2001).
H. Yazawa et al., “The FASEB Journal”, vol. 15, pp. 2454-2462, (2001).
L. Bao et al., “Genomics”, vol. 13, pp. 437-440 (1992).
A. Betten et al., “The Journal of Clinical Investigation”, vol. 108, No. 8, pp. 1221-1228 (2001).
D. Yang et al., “Journal of Leukocyte Biology”, vol. 72, pp. 598-607, (2002).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of screening therapeutic agents for nerve... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of screening therapeutic agents for nerve..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening therapeutic agents for nerve... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3835050

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.